Thyromimetics for the treatment of fatty liver diseases

Details for Australian Patent Application No. 2006249350 (hide)

Owner Metabasis Therapeutics, Inc.

Inventors Cable, Edward E.; Erion, Mark D.

Agent Spruson & Ferguson

Pub. Number AU-B-2006249350

PCT Pub. Number WO2006/128058

Priority 60/684,572 26.05.05 US

Parent 2004293013

Filing date 26 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 16 February 2012

International Classifications

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61K 31/28 (2006.01) - Compounds containing heavy metals

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 31/662 (2006.01) - Phosphorus acids or esters thereof having PC bonds, e.g. foscarnet, trichlorfon

A61K 31/665 (2006.01) - having oxygen as a ring hetero atom, e.g. fosfomycin

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

C07F 9/06 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/30 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/38 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/40 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/44 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/572 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/58 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/655 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6571 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/128058 Priority application(s): WO2006/128058

16 February 2012 Application Accepted

  Published as AU-B-2006249350

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249353-Electromagnetic energy emitting device with increased spot size

2006249349-Oral dosage forms comprising progesterone and methods of making and using the same